These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 9413269)

  • 1. Cytokine mRNA expression in CSF and peripheral blood mononuclear cells in multiple sclerosis: detection by RT-PCR without in vitro stimulation.
    Monteyne P; Van Laere V; Marichal R; Sindic CJ
    J Neuroimmunol; 1997 Dec; 80(1-2):137-42. PubMed ID: 9413269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Data on cytokine mRNA expression in CSF and peripheral blood mononuclear cells from MS patients as detected by PCR.
    Monteyne P; Sindic CJ
    Mult Scler; 1998 Jun; 4(3):143-6. PubMed ID: 9762664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of costimulatory molecules and cytokines in CSF and peripheral blood mononuclear cells from multiple sclerosis patients.
    Monteyne P; Van Antwerpen MP; Sindic CJ
    Acta Neurol Belg; 1999 Mar; 99(1):11-20. PubMed ID: 10218088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple sclerosis is associated with an imbalance between tumour necrosis factor-alpha (TNF-alpha)- and IL-10-secreting blood cells that is corrected by interferon-beta (IFN-beta) treatment.
    Ozenci V; Kouwenhoven M; Huang YM; Kivisäkk P; Link H
    Clin Exp Immunol; 2000 Apr; 120(1):147-53. PubMed ID: 10759776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prior poliomyelitis-evidence of cytokine production in the central nervous system.
    Gonzalez H; Khademi M; Andersson M; Wallström E; Borg K; Olsson T
    J Neurol Sci; 2002 Dec; 205(1):9-13. PubMed ID: 12409177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of IFN-gamma, IL-4, and TGF-beta in multiple sclerosis in relation to HLA-Dw2 phenotype and stage of disease.
    Söderström M; Hillert J; Link J; Navikas V; Fredrikson S; Link H
    Mult Scler; 1995 Nov; 1(3):173-80. PubMed ID: 9345450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [IL-2, IFN-gamma, and TNF-alpha mRNA expression in peripheral blood mononuclear cells in patients with multiple sclerosis].
    Lin J; Li L; Gao Y; Min B; Xu X
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1997 Feb; 19(1):24-8. PubMed ID: 10453548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prior poliomyelitis-IVIg treatment reduces proinflammatory cytokine production.
    Gonzalez H; Khademi M; Andersson M; Piehl F; Wallström E; Borg K; Olsson T
    J Neuroimmunol; 2004 May; 150(1-2):139-44. PubMed ID: 15081258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The phosphodiesterase i.v. inhibitor rolipram in vitro reduces the numbers of MBP-reactive IFN-gamma and TNF-alpha mRNA expressing blood mononuclear cells in patients with multiple sclerosis.
    Navikas V; Matusevicius D; Söderström M; Pirskanen R; Fredrikson S; Link H
    Clin Neuropharmacol; 1998; 21(4):236-44. PubMed ID: 9704165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Semi-quantitative analysis of cytokine gene expression in blood and cerebrospinal fluid cells by reverse transcriptase polymerase chain reaction.
    Rieckmann P; Albrecht M; Ehrenreich H; Weber T; Michel U
    Res Exp Med (Berl); 1995; 195(1):17-29. PubMed ID: 7784700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interferon-gamma, interleukin-4 and transforming growth factor-beta mRNA expression in multiple sclerosis and myasthenia gravis.
    Link J
    Acta Neurol Scand Suppl; 1994; 158():1-58. PubMed ID: 7732782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optic neuritis and cytokines: no relation to MRI abnormalities and oligoclonal bands.
    Kivisäkk P; Tian W; Matusevicius D; Link H; Söderström M
    Neurology; 1998 Jan; 50(1):217-23. PubMed ID: 9443483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytokine gene expression in cells derived from CSF of multiple sclerosis patients.
    Calabresi PA; Tranquill LR; McFarland HF; Cowan EP
    J Neuroimmunol; 1998 Aug; 89(1-2):198-205. PubMed ID: 9726843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple sclerosis: the proinflammatory cytokines lymphotoxin-alpha and tumour necrosis factor-alpha are upregulated in cerebrospinal fluid mononuclear cells.
    Matusevicius D; Navikas V; Söderström M; Xiao BG; Haglund M; Fredrikson S; Link H
    J Neuroimmunol; 1996 May; 66(1-2):115-23. PubMed ID: 8964905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. B7-1 (CD80), B7-2 (CD86), interleukin-12 and transforming growth factor-beta mRNA expression in CSF and peripheral blood mononuclear cells from multiple sclerosis patients.
    Monteyne P; Guillaume B; Sindic CJ
    J Neuroimmunol; 1998 Nov; 91(1-2):198-203. PubMed ID: 9846836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduction of both pro- and anti-inflammatory cytokines after 6 months of interferon beta-1a treatment of multiple sclerosis.
    Khademi M; Wallström E; Andersson M; Piehl F; Di Marco R; Olsson T
    J Neuroimmunol; 2000 Mar; 103(2):202-10. PubMed ID: 10696916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of palladium nanoparticles on the cytokine release from peripheral blood mononuclear cells of palladium-sensitized women.
    Reale M; Vianale G; Lotti LV; Mariani-Costantini R; Perconti S; Cristaudo A; Leopold K; Antonucci A; Di Giampaolo L; Iavicoli I; Di Gioacchino M; Boscolo P
    J Occup Environ Med; 2011 Sep; 53(9):1054-60. PubMed ID: 21866053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of interferon-gamma (IFN-gamma), IL-10, IL-12 and transforming growth factor-beta (TGF-beta) mRNA in synovial fluid cells from patients in the early and late phases of rheumatoid arthritis (RA).
    Bucht A; Larsson P; Weisbrot L; Thorne C; Pisa P; Smedegård G; Keystone EC; Grönberg A
    Clin Exp Immunol; 1996 Mar; 103(3):357-67. PubMed ID: 8608632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytokine mRNA levels in mononuclear blood cells from patients with multiple sclerosis.
    Rieckmann P; Albrecht M; Kitze B; Weber T; Tumani H; Broocks A; Lüer W; Poser S
    Neurology; 1994 Aug; 44(8):1523-6. PubMed ID: 8058164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of natalizumab on inflammatory mediators in multiple sclerosis: prospects for treatment-sensitive biomarkers.
    Khademi M; Bornsen L; Rafatnia F; Andersson M; Brundin L; Piehl F; Sellebjerg F; Olsson T
    Eur J Neurol; 2009 Apr; 16(4):528-36. PubMed ID: 19220425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.